Author

J. M. Obiero

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 2 Microbiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 3 Assay:proteomics· 3 Research Focus:cell type annotation· 2 Approach:experimental assay· 2 Assay:bulk RNA-seq· 1 Research Focus:cell-cell communication· 1 Research Focus:differential expression· 1 Research Focus:host-pathogen & immune response· 1

Frequent Co-Authors

P. L. Felgner· 3 shared A. Jain· 2 shared A. Jasinskas· 2 shared D. K. Milton· 2 shared H. Davies· 2 shared Prometheus Study Group· 2 shared R. Nakajima· 2 shared R. R. de Assis· 2 shared

Activity by Year

2020-2021 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersImmunology

P. L. Felgner

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Novel functional insights from the Plasmodium falciparum sporozoite-specific proteome by probabilistic integration of 26 studies

L. Meerstein-Kessel, J. Venhuizen, D. Garza, E. J. Vos, J. M. Obiero, P. L. Felgner, R. W. Sauerwein, M. Peters, A. S. P. Yang, M. A. Huynen

This paper identifies sporozoite-specific and enriched proteins in Plasmodium falciparum by integrating 26 transcriptomic and proteomic studies, revealing key pathways and potential vaccine targets.

PLOS Computational Biology · Apr 30, 2021Peer-reviewedMicrobiology

Analysis of SARS-CoV-2 Antibodies in COVID-19 Convalescent Blood using a Coronavirus Antigen Microarray

R. R. de Assis, A. Jain, R. Nakajima, A. Jasinskas, J. Felgner, J. M. Obiero, O. O. Adenaiye, S. Tai, F. H. Hong, P. Norris, M. Stone, G. Simmons, A. Bagri, M. Schreiber, A. Buser, , S. Khan

This paper validates a coronavirus antigen microarray to distinguish SARS-CoV-2 convalescent blood from pre-pandemic controls, showing improved discrimination with spike and nucleoprotein antigens.

bioRxiv · Apr 15, 2020Immunology

Analysis of Serologic Cross-Reactivity Between Common Human Coronaviruses and SARS-CoV-2 Using Coronavirus Antigen Microarray

S. Khan, R. Nakajima, A. Jain, R. R. de Assis, A. Jasinskas, J. M. Obiero, O. Adenaiye, S. Tai, F. Hong, D. K. Milton, H. Davies, P. L. Felgner, Prometheus Study Group

The paper develops a coronavirus antigen microarray to study serologic cross-reactivity between common human coronaviruses and SARS-CoV-2, finding high IgG reactivity to common coronaviruses and low reactivity to SARS-CoV-2 with some cross-reactivity to conserved antigens.

bioRxiv · Mar 24, 2020 · PreprintImmunology